Back

Maternal medication use patterns during the periconceptional period and risk of congenital heart defects: A nationwide register-based cohort study

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Adult congenital heart disease: special conditions Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giaan Ninh

Herlev Hospital, Herlev (Denmark)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor J. Hlebowicz (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Doctor P. Pantelidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Assistant Professor M. Yadollahi (Tehran, IR)
Abstract
Presentation thumbnail
Miss A. De Keijzer (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Adult congenital heart disease: special conditions

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
First trimester maternal infections and offspring congenital heart defects: a systematic review and meta-analysis
2 September 2024
thumbnail
Congress Presentation
Pregnancy protection in women of child-bearing age prescribed ACE inhibitors, ARBs or statins - A nationwide cohort study
30 August 2024
thumbnail
Congress Presentation
Maternal fluconazole use during the third trimester and risk of QT prolongation in the offspring
29 August 2025
thumbnail
Congress Presentation
Prepregnancy obesity, adverse pregnancy outcome patterns, and early postpartum cardiometabolic risk: a mediation analysis identified by latent class analysis
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources